Rexahn Pharmaceuticals CEO Mina Sooch's 2022 pay jumps 67% to $1.3M
Rexahn Pharmaceuticals reports 2022 executive compensation
By ExecPay News
Published: May 1, 2023
Rexahn Pharmaceuticals reported fiscal year 2022 executive compensation information on May 1, 2023.
In 2022, three executives at Rexahn Pharmaceuticals received on average a compensation package of $762K, a 57% increase compared to previous year.
Average pay of disclosed executives at Rexahn Pharmaceuticals
Mina Sooch, Chief Executive Officer, received $1.3M in total, which increased by 67% compared to 2021. 41% of Sooch's compensation, or $550K, was in salary. Sooch also received $303K in non-equity incentive plan, $459K in option awards, as well as $30K in other compensation.
Amy Rabourn, Vice President of Finance, received a compensation package of $499K, which increased by 50% compared to previous year. 52% of the compensation package, or $260K, was in salary.
Bernhard Hoffmann, Vice President of Corporate Development and Operations, earned $446K in 2022, a 37% increase compared to previous year.
Related executives
You may also like
Source: SEC filing on May 1, 2023.